In an industry strapped for financial support due to regulations and ever-tightening corporate budgets, it’s not always easy for biotechs to do what they do best: innovate. That means it’s not so easy for pharma companies to source their next innovative pharmaceutical development. What can biotechs and pharma companies do amid this innovation stagnation?
Here, James Hattersley, VP of Business Development for Sun Pharmaceutical Industries, talks about the way forward.
Jim will be speaking at the next BioNetwork conference, taking place in October at the beautiful Ritz Carlton, Laguna Niguel, California. Visit the website to learn more.
Sorry we couldn't complete your registration. Please try again.
You must accept the Terms and conditions to register